ANDA 205249, held by Zydus Lifesciences. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 205249 (Clobetasol Propionate), held by Zydus Lifesciences, was first approved by FDA on Sep 24, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 24, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% ยท lotion;topical | Clobetasol Propionate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters